Company news
Bluenergies Ltd. news in 2008
Bluenergies Ltd.'s news releases, calls and decks from 2008, newest first.
BELLUS Health announces formal notice to voluntarily delist from NASDAQ
December 17, 2008
BELLUS Health is Preparing to Voluntarily Delist from the NASDAQ Capital Market
December 5, 2008
BELLUS Health Announces Stock Listing Transfer from NASDAQ Global Market to NASDAQ Capital Market
November 13, 2008
BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update
November 10, 2008
BELLUS Health to present at the Rodman and Renshaw 10th Annual Healthcare Conference
November 6, 2008
BELLUS Health provides update on activities
October 21, 2008
BELLUS Health Receives Nasdaq Deficiency Notice Relating to Market Value
October 15, 2008
VIVIMIND(TM), Canada's scientifically proven natural health product to protect memory function, is available starting today
September 2, 2008
Correction from source - BELLUS Health
August 12, 2008
BELLUS Health moves forward on nutraceutical and pharmaceutical fronts - Reports Results for First Half of 2008
August 5, 2008
BELLUS Health announces closing of Innodia acquisition
July 17, 2008
BELLUS Health signs agreement to acquire Innodia
July 16, 2008
BELLUS Health to present at the Rodman and Renshaw 5th Annual Global Healthcare Conference
May 15, 2008
BELLUS HEALTH reports results for first quarter of fiscal 2008
May 5, 2008
At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM)
April 15, 2008
Media advisory - Neurochem's Annual and Special Meeting of Shareholders April 15, 2008
April 11, 2008
Neurochem Annual and Special Meeting of shareholders
April 11, 2008
Neurochem moves eprodisate (KIACTA(TM)) drug development program forward for Amyloid A amyloidosis
March 13, 2008
Neurochem announces departure of two members of management team
February 21, 2008
Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives
February 20, 2008
/C O R R E C T I O N from source -- Neurochem Inc./
February 13, 2008
Neurochem to present at 2008 BIO CEO & Investor Conference - Presentation will be Web cast live
February 11, 2008
Neurochem appoints Mr. Gary Schmid as CEO of new nutraceutical business
January 30, 2008
Neurochem to present at JPMorgan Healthcare Conference
January 3, 2008